Witryna364,900. 14.822%. $15,745. Back to IMGN Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. … Witryna6 kwi 2024 · A high-level overview of ImmunoGen, Inc. (IMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
ImmunoGen, Inc. (IMGN) Stock Price, Quote & News - Stock …
Witryna29 mar 2024 · IMGN has an average analyst rating of buy and is -69.05% away from its mean target price of $12.44 per share. Its trailing 12 month earnings per share (EPS) is $-0.77 ... Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an … Witryna27 mar 2024 · Companies. ImmunoGen Inc. (NASDAQ:IMGN) traded at $3.79 at close of the session on Friday, 03/24/23, made an upward move of 1.61% on its previous day’s price. Looking at the stock we see that its previous close was $3.73 and the beta (5Y monthly) reads 0.85 with the day’s price range being $3.66 – $3.83. In terms of its 52 … dashed rectangle翻译
ImmunoGen, Inc. (IMGN) Stock Price Today, Quote & News
Witryna15 gru 2024 · Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ... Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant … dashed plot matplotlib